Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
The Functional Epigenomics Lab studies how chromatin affects cellular programs with a specific focus on the enhancer regulatory function in stem cell states, cancer progression and drug resistance.
Dr. Maia and his research team focus on epigenomic profiling to understand how expression patterns are modulated in different tumor cells, which can lead to individualized treatment for people with cancer.
Dr. Maia leads research efforts with expert faculty to discover why cancer cells are resistant to drug therapies.
Education and training opportunities are available for fellows, graduate students and undergraduates interested in functional epigenomics research.
Contact Dr. Maia about his research or for information about opportunities for research in the Functional Epigenomics Lab.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.